259 related articles for article (PubMed ID: 10843744)
1. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
Flisiak R; Pytel-Krolczuk B; Prokopowicz D
Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
[TBL] [Abstract][Full Text] [Related]
2. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
[TBL] [Abstract][Full Text] [Related]
3. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
4. [Effect of polymorphism of transforming growth factor beta1 gene on HBV-induced liver cirrhosis].
Yang ZX; Wang H; Gao CF; Xu LL; Zhao WJ
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1021-6. PubMed ID: 16029542
[TBL] [Abstract][Full Text] [Related]
5. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
7. Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma.
Okumoto K; Hattori E; Tamura K; Kiso S; Watanabe H; Saito K; Saito T; Togashi H; Kawata S
Liver Int; 2004 Feb; 24(1):21-8. PubMed ID: 15101997
[TBL] [Abstract][Full Text] [Related]
8. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
[TBL] [Abstract][Full Text] [Related]
9. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
[TBL] [Abstract][Full Text] [Related]
10. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
[TBL] [Abstract][Full Text] [Related]
12. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Cytokine; 2001 Jun; 14(6):343-6. PubMed ID: 11497495
[TBL] [Abstract][Full Text] [Related]
13. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
Berasain C; Herrero JI; García-Trevijano ER; Avila MA; Esteban JI; Mato JM; Prieto J
Hepatology; 2003 Jul; 38(1):148-57. PubMed ID: 12829997
[TBL] [Abstract][Full Text] [Related]
14. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
15. [The effect of serum TGFb1 of patients with chronic hepatitis B in liver fibrosis formation].
Liu F; Li B; Nan Y
Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):196-8. PubMed ID: 10715784
[TBL] [Abstract][Full Text] [Related]
16. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J
Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
Kozłowska J; Łoch T; Jabłońska J; Cianciara J
Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
[TBL] [Abstract][Full Text] [Related]
18. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
[TBL] [Abstract][Full Text] [Related]
19. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
Campillo B; Sherman E; Richardet JP; Bories PN
Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]